Amphastar Pharmaceuticals, Inc.
AMPH· Nasdaq
AMPHAmphastar Pharmaceuticals, Inc.
Source filing unavailable
| Metric | Q1 2014 | Q1 2013 |
|---|---|---|
| Revenue | $45.87M | $52.96M |
| Net Income | -$1.62M | $2.38M |
| EPS Diluted | -$0.04 | $0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Amphastar Pharmaceuticals, Inc. · CIK 1297184 · Engraved from SEC EDGAR
